XNAS · ENVB
-0.70% · -$0.0100 · Vol 80.8K
Market closed · last close 4:00 PM ET · price as of 16:10:57 ET
Enveric Biosciences, Inc. Common Stock

Enveric Biosciences, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$1.41
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is ENVB moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for ENVB are being assembled.
About Enveric Biosciences, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Listed since
1995
Employees
6
Country
US

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.41
Day high
$1.43
Day low
$1.36
Previous close
$1.42
52W high
$1.63
-13.50% from high
52W low
$1.28
37% of range
Market cap
$5.7M
EPS
$-14.0800
Shares out
4M
Volume
80.8K
VWAP
$1.39
Price history computed in-house
1W
-4.41%
1M
-13.50%
SMA 50 $1.41 · below
SMA 200 $1.41 · below
52W position 37%
Veridion warehouse edge

Warehouse intelligence for ENVB.

Veridion Score
72
0: 941: 472: 333: 704: 795: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

ENVB insider activity

Enveric Biosciences, Inc. Common Stock

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for ENVB.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

ENVB contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ENVB in this window.
Lobbying spend

ENVB lobbying filings, year to date.

Registered lobbying filings matched to Enveric Biosciences, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ENVB in this window.
Latest news · ENVB
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for ENVB.
Options
Sovereign unlock shows live options positioning for ENVB.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.